Japan Dna Diagnostics Market Size & Outlook, 2023-2030

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.

Pcr-based diagnostics was the largest segment with a revenue share of 49.73% in 2023. Horizon Databook has segmented the Japan dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.

Japan is one of the most advanced countries in this region, and its market is expected to grow rapidly, due to high government spending to control cancer prevalence. The increase in cancer prevalence can be attributed to rapid growth in the geriatric population. Japan has a median age of 44 years, one of the highest in the world. In contrast to other Asia Pacific countries, Japan offers country-wide cancer screening programs to combat its growing prevalence. These programs offer cancer screening to over 94% of the population.

However, stringent policies by regulatory agencies may delay the introduction of newer technologies in the market, which may hamper market growth during the forecast period. Several developments by market players in the country are contributing to market growth. For instance, in November 2019, Toshiba Corporation announced the development of a method for cancer detection using mRNA in blood. In addition, in May 2019, Chugai Pharmaceutical Co., Ltd. conducted an educational campaign to promote cervical cancer screening among women aged 21 years and above.

This awareness campaign was conducted in partnership with the local governments, including Yokohama & Osaka, and other universities. The company encouraged its female employees to undergo cervical cancer screening. Through this educational campaign, Chugai intended to increase awareness among women aged 21 years and above.